Veterinary Sedative in Illegal Drugs Sparks Health Alert

The U.S. Centers for Disease Control and Prevention issued a critical health advisory on April 2, 2026, warning of the increasing detection of medetomidine, a veterinary sedative, within the illicit drug supply across various U.S. jurisdictions.

This sedative, referred to as 'rhino tranq' or 'dex,' is approved for canine use but is not authorized for humans. It has been increasingly found in law enforcement seizures and wastewater samples, with the Northeast region reporting the highest concentrations. Its presence in the fentanyl supply has been linked to severe withdrawal symptoms, including hypertension and anxiety, as well as profound sedation.

From mid-2023 to mid-2024, medetomidine was identified sporadically with fentanyl in cities like Chicago, Philadelphia, and Pittsburgh. The CDC noted that stopping medetomidine after regular use can trigger a severe withdrawal syndrome requiring potential emergency care. Because fentanyl is often involved, naloxone remains a critical intervention for respiratory depression.

As of January 2026, medetomidine was detected weekly in wastewater in at least one of 14 participating U.S. states, underscoring an ongoing public health concern.